Dual biologic therapy may serve as a suitable treatment choice for patients with IBD who have not responded to current therapies.

For both induction and maintenance therapy, subcutaneous guselkumab significantly improves clinical outcomes in patients with ...

Agnico Eagle Mines is the IBD Stock Of The Day amid furious earnings growth and surging gold prices. On Tuesday, the gold ...

A retrospective population-based study showed that severe obesity and bariatric surgery independently increased the risk of inflammatory bowel disease.

For patients with inflammatory bowel disease (IBD), risk factors associated with Clostridioides difficile infection (CDI) include recent diagnosis, corticosteroid usage, and hospitalization.

Crohn’s disease can cause digestive issues However since it is an inflammatory disease the symptoms can go beyond the gut ...

Nationally recognized pediatric gastroenterologist, Michael Dolinger, MD, MBA, joins Hassenfeld Children's Hospital at NYU Langone as director of the Pediatric Inflammatory Bowel Disease Program ...

Better cardiovascular safety and lower risk of all-cause mortality was observed among older adult patients with IBD who received ustekinumab vs vedolizumab.

One study found that a majority of apps for irritable bowel disease (IBD), which includes Crohn’s and ulcerative colitis, have these important downsides: Lack of medical professionals in the ...

Physiological metrics captured via wearable devices may help identify and predict flares in inflammatory bowel disease, ...

Several tests and exams are available to help doctors identify IBD and distinguish between the two types. An accurate diagnosis is the first step to successful treatment and management of your ...